Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216073.RAVPh09FGWrUIXaorpyKS5XJ_hNI4Y73ueK3hSrDdiMjc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216073.RAVPh09FGWrUIXaorpyKS5XJ_hNI4Y73ueK3hSrDdiMjc130_assertion type Assertion NP1216073.RAVPh09FGWrUIXaorpyKS5XJ_hNI4Y73ueK3hSrDdiMjc130_head.
- NP1216073.RAVPh09FGWrUIXaorpyKS5XJ_hNI4Y73ueK3hSrDdiMjc130_assertion description "[Furthermore, we find that downregulation of FHL2 frequently occurs in myelodysplastic syndrome and acute myeloid leukemia patients, raising a possibility that FHL2 downregulation has a role in the pathogenesis of myeloid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216073.RAVPh09FGWrUIXaorpyKS5XJ_hNI4Y73ueK3hSrDdiMjc130_provenance.
- NP1216073.RAVPh09FGWrUIXaorpyKS5XJ_hNI4Y73ueK3hSrDdiMjc130_assertion evidence source_evidence_literature NP1216073.RAVPh09FGWrUIXaorpyKS5XJ_hNI4Y73ueK3hSrDdiMjc130_provenance.
- NP1216073.RAVPh09FGWrUIXaorpyKS5XJ_hNI4Y73ueK3hSrDdiMjc130_assertion SIO_000772 25179730 NP1216073.RAVPh09FGWrUIXaorpyKS5XJ_hNI4Y73ueK3hSrDdiMjc130_provenance.
- NP1216073.RAVPh09FGWrUIXaorpyKS5XJ_hNI4Y73ueK3hSrDdiMjc130_assertion wasDerivedFrom befree-2016 NP1216073.RAVPh09FGWrUIXaorpyKS5XJ_hNI4Y73ueK3hSrDdiMjc130_provenance.
- NP1216073.RAVPh09FGWrUIXaorpyKS5XJ_hNI4Y73ueK3hSrDdiMjc130_assertion wasGeneratedBy ECO_0000203 NP1216073.RAVPh09FGWrUIXaorpyKS5XJ_hNI4Y73ueK3hSrDdiMjc130_provenance.